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In irtroducing this third session ofthe Conference, let us pause
for a moment to see where we have been in the first two sessions.
The descriptive epidemiology of feral fish populations strong-
ly suggests that enzootics ofneoplasms are associated with con-
tamination of their environment with carcinogens, procar-
cinogens, and cancer promoters. Detailed biochemical studies
on fish and shellfish from contaminated and clean localities fur-
ther implicate xenobiotics in these enzootics. Furthermore, the
edible portions of fish and shellfish have been shown to contain
residues of some xenobictics and their metabolites.
To what extent, then, do these enzootics represent a public
health warning to human populations that might consume fish or
shellfish from these contaminated habitats? In this third session
we begin to examine this question.
In assessing risks we need to know a number of things:
a) What are the conditions ofexposure? Who is being exposed;
to what; in what amounts and frequencies; in what way?We have
already heard in previous sessions about sonme ofthe carcinogens
found in habitats where fish suffer increased rates ofneoplasms,
but there is still a great deal about these environments that we do
not know as yet. Moreover, there is much to learn about the
prevalence and nature ofcarcinctgens, procarcinogens, and pro-
moters in the edible portions of fish and shellfish. Even if we
were to fill in these gaps, we must still determine the extent to
which human populations consume fish and shellfish in general,
and from contaminated environments in particular.
b) Identify adverse effects and relate these effects quantitatively
to dose (i.e., establish a dose-response relationship). As already
noted. a number ofknown and putative carcinogens have been
found in polluted habitats where feral fish populations show
evidence of increased rates ofneoplasms. However, the extent to
which th.ese or other carcinogens are passed up the ibod chain to
hurmans and the possibility that they undergo transformation
along the way to forms that may be more or less hamfu tan the
original remains to be determined in most instances.
James Huff of NIEHS will discuss one standard method of
identifying caricer risk in complex mixtures, the rodent chronic
boassay; Huffdiscusses the considerations involved in conduc-
ting such a te-st and the feasibility of doing so.
There is also controversy as to the nechanisms whereby some
xenobiotics might contribute to cancer. This problem is exempli-
fied by PCBs, which are common contaminants in fish. IfPCBs
are promoters rather than initiators ofcancer, there are some who
feel that the dose-response curve will be quite different. In his
paper, John Weisburger of the American Health Foundation
discusses the distinctions between genotoxic and nongenotoxic
chemicals and outlines some methods whereby these two classes
of chemicals may be distinguished from each other.
In connection with the question of identifying adverse effects,
I should note that this Conference has focused on the cancer risks
to human populations. It is not at all obvious, however, that
cancer is the most likely adverse outcome to result from consum-
ing contaminated fish and shellfish. There is already some
epidemiological evidence that infants born to mothers that con-
sumed PCB-contaminated fish might suffer some slowing in
their behavioral development. Noncancer risks, however, were
not considered at this Conference.
c) Estimate the risks by applying information about dose-
response relationships for an adverse effect to the conditions of
exposure in the population. Clearly, there are significant uncer-
tainties in the data on exposure, adverse effects, and dose-
response relationships. However, it is sfill often desirable to make
an estimate of the risk, even given these uncertainties. Such a
detailed risk assessment has been carried out for Quincy Bay in
Massachusetts, and is presented by Charles Cooper ofMetcalf
and Eddy. It is conventional practice in such exercises to make
rather conservative assumptions when confronting the gaps in
the data. Despite this, such assessments can be very valuable in
indicating situations where, despite such assumptions, the risks
seem to be small. Thus, ataminimum, risk assessments can sug-
gest that there is unlikely to be a significant problem. In the case
of Quincy Bay, the assessment did not result in a clean bill of
health. It does, however, allow us to locate some boundaries on
the risk problem and to identify important data gaps.
Ulfimately, it is the experience ofhuman populations that is the
most persuasive to people. Inmy paper, written in collaboration
with Matdtew Longnecker ofthe University ofCalifornia at Los
Angeles, we discuss the potential of human epidemiological
studies to ascertain the existence ofa human cancer risk.
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